Mostrar el registro sencillo del ítem
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
| dc.contributor.author | Trujillo Rodríguez, María | |
| dc.contributor.author | Praena Fernández, Juan Manuel | |
| dc.date.accessioned | 2023-05-22T09:05:17Z | |
| dc.date.available | 2023-05-22T09:05:17Z | |
| dc.date.issued | 2022-07-14 | |
| dc.identifier.citation | Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Ferna´ndez JM, Pe´rez- Go´mez A, Gasca-Capote C, et al. (2022) Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE 17(7): e0269875. [https://doi.org/10.1371/journal.pone.0269875] | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10481/81702 | |
| dc.description.abstract | Background The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Methods Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. Results 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Conclusions Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. | es_ES |
| dc.description.sponsorship | Consejeria de Salud y Familia COVID-00052020 RH-0037-2020 | es_ES |
| dc.description.sponsorship | Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades PY20/01276 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III CP19/00159 CP19/00146 FI19/00304 FI19/00083 COV20/00698 | es_ES |
| dc.description.sponsorship | Red Tematica de Investigacion Cooperativa en SIDA RD16/0025/0020 RD16/0025/0006 RD16/0025/0026 | es_ES |
| dc.description.sponsorship | European Commission | es_ES |
| dc.description.sponsorship | Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain CB21/13/00020 | es_ES |
| dc.description.sponsorship | Spanish Research Council (CSIC) | es_ES |
| dc.description.sponsorship | IISPV 2019/IISPV/05 | es_ES |
| dc.description.sponsorship | GeSIDA | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Plos | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.title | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients | es_ES |
| dc.title.alternative | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1371/journal.pone.0269875 | |
| dc.type.hasVersion | VoR | es_ES |
